Ramakrishnan Natesan

Dr. Ramakrishnan Natesan

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
RRReyaz Ur Rasool
Reyaz Ur Rasool
RNRamakrishnan Natesan
Ramakrishnan Natesan
QDQu Deng
Qu Deng
SAShweta Aras
Shweta Aras
PLPriti Lal
Priti Lal
IAIrfan A. Asangani
Irfan A. Asangani
Metastatic castration-resistant prostate cancer (CRPC) is a fatal disease, primarily resulting from the transcriptional addiction driven by androgen receptor (AR). First-line CRPC treatments typically target AR signaling, but are rapidly bypassed, resulting in only a modest survival benefit with antiandrogens. Therapeutic approaches that more effectively block the AR-transcriptional axis are urgently needed. Here, we investigated the molecular mechanism underlying the association between the transcriptional coactivator MED1 and AR as a vulnerability in AR-driven CRPC. MED1 undergoes CDK7-dependent phosphorylation at T1457 and physically engages AR at superenhancer sites, and is essential for AR-mediated transcription. In addition, a CDK7-specific inhibitor, THZ1, blunts AR-dependent neoplastic growth by blocking AR/MED1 corecruitment genome-wide, as well as reverses the hyperphosphorylated MED1-associated enzalutamide-resistant phenotype. In vivo, THZ1 induces tumor regression of AR-amplified human CRPC in a xenograft mouse model. Together, we demonstrate that CDK7 inhibition selectively targets MED1-mediated, AR-dependent oncogenic transcriptional amplification, thus representing a potential new approach for the treatment of CRPC. Significance: Potent inhibition of AR signaling is critical to treat CRPC. This study uncovers a driver role for CDK7 in regulating AR-mediated transcription through phosphorylation of MED1, thus revealing a therapeutically targetable potential vulnerability in AR-addicted CRPC. See related commentary by Russo et al., p. 1490. This article is highlighted in the In This Issue feature, p. 1469

1 March 2013 in Biophysical Journal
Verified
Journal Article
Closed access
RNRamakrishnan Natesan
Ramakrishnan Natesan
PKP.B. Sunil Kumar
P.B. Sunil Kumar
JIJohn H. Ipsen
John H. Ipsen

1 September 2020 in Cell Reports
Verified
Journal Article
Open access
JCJie Chen
Jie Chen
SHShane M. Harding
Shane M. Harding
RNRamakrishnan Natesan
Ramakrishnan Natesan
LTLei Tian
Lei Tian
JBJoseph L. Benci
Joseph L. Benci
RGROGER A GREENBERG
ROGER A GREENBERG
The DNA-dependent pattern recognition receptor, cGAS (cyclic GMP-AMP synthase), mediates communication between the DNA damage and the immune responses. Mitotic chromosome missegregation stimulates cGAS activity; however, it is unclear whether progression through mitosis is required for cancercell-intrinsic activation of anti-tumor immune responses. Moreover, it is unknown whether cell cycle checkpoint disruption can restore responses in cancer cells that are recalcitrant to DNAdamage-induced inflammation. Here, we demonstrate that prolonged cell cycle arrest at the G2-mitosis boundary from either excessive DNA damage or CDK1 inhibition prevents inflammatory-stimulated gene expression and immune-mediated destruction of distal tumors. Remarkably, DNAdamage-induced inflammatory signaling is restored in a RIG-I-dependent manner upon concomitant disruption of p53 and the G2 checkpoint. These findings link aberrant cell progression and p53 loss to an expanded spectrum of damage-associated molecular pattern recognition and have implications for the design of rational approaches to augment anti-tumor immune responses.

1 October 2014 in Physics Reports
Verified
Journal Article
Closed access
RNRamakrishnan Natesan
Ramakrishnan Natesan
PKP.B. Sunil Kumar
P.B. Sunil Kumar
Ravi RadhakrishnanRavi Radhakrishnan
Ravi Radhakrishnan

29 April 2010 in Physical Review E
Verified
Journal Article
Closed access
RNRamakrishnan Natesan
Ramakrishnan Natesan
PKP. B. Sunil Kumar
P. B. Sunil Kumar
JIJohn H. Ipsen
John H. Ipsen
We present a method for simulating fluid vesicles with in-plane orientational ordering. The method involves computation of local curvature tensor and parallel transport of the orientational field on a randomly triangulated surface. It is shown that the model reproduces the known equilibrium conformation of fluid membranes and work well for a large range of bending rigidities. Introduction of nematic ordering leads to stiffening of the membrane. Nematic ordering can also result in anisotropic rigidity on the surface leading to formation of membrane tubes.

18 March 2020 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
SYSalina Yuan
Salina Yuan
RNRamakrishnan Natesan
Ramakrishnan Natesan
FSFrancisco J. Sanchez-Rivera
Francisco J. Sanchez-Rivera
JLJinyang Li
Jinyang Li
NBNatarajan V. Bhanu
Natarajan V. Bhanu
BSBen Z. Stanger
Ben Z. Stanger
Epithelial plasticity, reversible modulation of a cell's epithelial and mesenchymal features, is associated with tumor metastasis and chemoresistance, leading causes of cancer mortality. Although different master transcription factors and epigenetic modifiers have been implicated in this process in various contexts, the extent to which a unifying, generalized mechanism of transcriptional regulation underlies epithelial plasticity remains largely unknown. Here, through targeted CRISPR/Cas9 screening, we discovered two histone-modifying enzymes involved in the writing and erasing of H3K36me2 that act reciprocally to regulate epithelial-to-mesenchymal identity, tumor differentiation, and metastasis. Using a lysine-to-methionine histone mutant to directly inhibit H3K36me2, we found that global modulation of the mark is a conserved mechanism underlying the mesenchymal state in various contexts. Mechanistically, regulation of H3K36me2 reprograms enhancers associated with master regulators of epithelial-to-mesenchymal state. Our results thus outline a unifying epigenome-scale mechanism by which a specific histone modification regulates cellular plasticity and metastasis in cancer. Significance: Although epithelial plasticity contributes to cancer metastasis and chemoresistance, no strategies exist for pharmacologically inhibiting the process. Here, we show that global regulation of a specific histone mark, H3K36me2, is a universal epigenome-wide mechanism that underlies epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition in carcinoma cells. These results offer a new strategy for targeting epithelial plasticity in cancer. This article is highlighted in the In This Issue feature, p. 747